Literature DB >> 21969667

Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Yusuhn Kang1, Seung Hong Choi, Young-Jae Kim, Kwang Gi Kim, Chul-Ho Sohn, Ji-Hoon Kim, Tae Jin Yun, Kee-Hyun Chang.   

Abstract

PURPOSE: To explore the role of histogram analysis of apparent diffusion coefficient (ADC) maps based on entire tumor volume data in determining glioma grade and to evaluate the diagnostic performance of ADC maps at standard (1000 sec/mm(2)) and high (3000 sec/mm(2)) b values.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, and informed consent was waived. Twenty-seven patients with astrocytic tumors underwent diffusion-weighted magnetic resonance imaging with b values of 1000 and 3000 sec/mm(2), and the corresponding ADC maps were calculated (ADC(1000) and ADC(3000), respectively). Regions of interest containing the lesion were drawn on every section of the ADC map containing the tumor and were summated to derive volume-based data of the entire tumor. Histogram parameters were correlated with tumor grade by using repeated measurements analysis of variance, the Tukey-Kramer test for post hoc comparisons, and an unpaired Student t test. Receiver operating characteristic (ROC) curves were constructed to determine the optimum threshold for each histogram parameter, and sensitivity and specificity were assessed.
RESULTS: Minimum ADC(1000) and ADC(3000) both decreased with increasing tumor grade. The 50th and 75th percentiles of cumulative ADC(1000) histograms showed significant differences between grades (P = .015 and .001, respectively), while the fifth and 75th percentiles of cumulative ADC(3000) histograms showed such differences (P = .015 and .014, respectively). Minimum ADC and the fifth percentile for both ADC(1000) (P < .001 and P = .024, respectively) and ADC(3000) (P < .001 and P = .001, respectively) proved to be significant histogram parameters for differentiating high- from low-grade gliomas. The diagnostic value of the parameters derived from ADC(1000) and ADC(3000) were compared, and a significant difference (0.202, P = .014) was found between the areas under the ROC curve of the fifth percentiles for ADC(1000) and ADC(3000).
CONCLUSION: Histogram analysis of ADC maps based on entire tumor volume can be a useful tool for grading gliomas. The fifth percentile of the cumulative ADC histogram obtained at a high b value was the most promising parameter for differentiating high- from low-grade gliomas. © RSNA, 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969667     DOI: 10.1148/radiol.11110686

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  134 in total

1.  Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading.

Authors:  Avneesh Chhabra; Oganes Ashikyan; Chenelle Slepicka; Nathan Dettori; Helena Hwang; Alexandra Callan; Rohit R Sharma; Yin Xi
Journal:  Eur Radiol       Date:  2018-12-03       Impact factor: 5.315

2.  Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer.

Authors:  Hyeyeol Bae; Soichiro Yoshida; Yoh Matsuoka; Hiroshi Nakajima; Eisaku Ito; Hiroshi Tanaka; Miyako Oya; Takayuki Nakayama; Hideki Takeshita; Toshiki Kijima; Junichiro Ishioka; Noboru Numao; Fumitaka Koga; Kazutaka Saito; Takumi Akashi; Yasuhisa Fujii; Kazunori Kihara
Journal:  Int Urol Nephrol       Date:  2014-03       Impact factor: 2.370

3.  Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.

Authors:  Jiaxuan Zhang; Wenzhen Zhu; Rongwen Tain; Xiaohong Joe Zhou; Kejia Cai
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

4.  Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis.

Authors:  Ruofei Liang; Mao Li; Xiang Wang; Jiewen Luo; Yuan Yang; Qing Mao; Yanhui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Authors:  Ayan Debnath; Rakesh Kumar Gupta; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 6.  An Update on the Approach to the Imaging of Brain Tumors.

Authors:  Katherine M Mullen; Raymond Y Huang
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

7.  Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.

Authors:  Reza Farjam; Christina I Tsien; Felix Y Feng; Diana Gomez-Hassan; James A Hayman; Theodore S Lawrence; Yue Cao
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

8.  Pituitary macroadenoma: Accuracy of apparent diffusion coefficient magnetic resonance imaging in grading tumor aggressiveness.

Authors:  Mariko Doai; Hisao Tonami; Munetaka Matoba; Osamu Tachibana; Hideaki Iizuka; Satoko Nakada; Sohuske Yamada
Journal:  Neuroradiol J       Date:  2019-01-16

9.  Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.

Authors:  Rifaquat Rahman; Alhafidz Hamdan; Rebecca Zweifler; Han Jiang; Andrew D Norden; David A Reardon; Srinivasan Mukundan; Patrick Y Wen; Raymond Y Huang
Journal:  J Neurooncol       Date:  2014-05-08       Impact factor: 4.130

10.  Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index.

Authors:  Ren Yan; Pang Haopeng; Feng Xiaoyuan; Wu Jinsong; Zhang Jiawen; Yao Chengjun; Qiu Tianming; Xiong Ji; Sheng Mao; Ding Yueyue; Zhang Yong; Luo Jianfeng; Yao Zhenwei
Journal:  Neuroradiology       Date:  2015-10-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.